CD44 and cancer: To address whether the cancer stem cells enriched within SASVO3 may express molecules that are unique to stem cells and/or malignant cells, the expression levels of Bmi1, pAKT, CD133, CD44, Nanog, Oct-4, p21 and p14INK4A/ARF were determined.